Cargando…
PROTAC-Based Protein Degradation as a Promising Strategy for Targeted Therapy in Sarcomas
Sarcomas are heterogeneous bone and soft tissue cancers representing the second most common tumor type in children and adolescents. Histology and genetic profiling discovered more than 100 subtypes, which are characterized by peculiar molecular vulnerabilities. However, limited therapeutic options e...
Autores principales: | Mancarella, Caterina, Morrione, Andrea, Scotlandi, Katia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671294/ https://www.ncbi.nlm.nih.gov/pubmed/38003535 http://dx.doi.org/10.3390/ijms242216346 |
Ejemplares similares
-
Unraveling the IGF System Interactome in Sarcomas Exploits Novel Therapeutic Options
por: Mancarella, Caterina, et al.
Publicado: (2021) -
Novel Regulators of the IGF System in Cancer
por: Mancarella, Caterina, et al.
Publicado: (2021) -
Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Modulates Aggressiveness of Ewing Sarcoma by Regulating the CD164-CXCR4 Axis
por: Mancarella, Caterina, et al.
Publicado: (2020) -
Degradation of proteins by PROTACs and other strategies
por: Wang, Yang, et al.
Publicado: (2020) -
PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy
por: Qi, Si-Min, et al.
Publicado: (2021)